March 13 (Reuters) - Lucid Diagnostics Inc LUCD.O :
* LUCID DIAGNOSTICS PROVIDES BUSINESS UPDATE AND FOURTH
QUARTER
AND FULL YEAR 2022 FINANCIAL RESULTS
* LUCID DIAGNOSTICS INC - QTRLY LOSS PER SHARE $0.47
* LUCID DIAGNOSTICS INC - QTRLY ADJUSTED LOSS PER SHARE
$0.33
* COMPANY SECURES FINANCING OF $24.6 MILLION THROUGH
SEPARATE
OFFERINGS OF PREFERRED STOCK AND DEBT, CONVERTIBLE AFTER
SEPTEMBER 2023
* SIGNS IN-NETWORK AGREEMENT WITH LARGEST SECONDARY PPO,
MULTIPLAN, EXPANDING PATIENT ACCESS TO ESOGUARD
* Q4 EARNINGS PER SHARE VIEW $-0.38 -- REFINITIV IBES DATA
Source text for Eikon: ID:nPn2qrqsxa
Further company coverage: LUCD.O
((Reuters.Briefs@thomsonreuters.com;))